Secondary outcomes

Total RBC count
Repeated measure ANOVA with time as within subject factor and groups as between subject factor showed a significant effect of time F(2,70) =10.439, P < 0.001. Both groups showed significant improvement that sustained during the course of the treatment. There was a significant effect of group F(1,35) =15.866, P < 0.001 and group X time interaction F(2, 70) =3.379, P = 0.041. Post hoc analysis revealed at the end of 30 days (P = 0.019) and 60 days (P = 0.001) group K showed significant improvement compared to group D [Table 2b and Figure 2 ].
PCV
Repeated measure ANOVA with time as within subject factor and groups as between subject factor showed a significant effect of time F(2,70) =83.074, P < 0.001. Both groups showed significant improvement that sustained during the course of the treatment. There was a significant effect of group F(1,35) =16.454, P < 0.001 and group X time interaction F(2,70) =12.113, P < 0.001. Post hoc analysis revealed at the end of 30 days (P = 0.008) and 60 days (P < 0.001) group K showed significant improvement compared to group D [Table 2b and Figure 3 ].
MCV
Repeated measure ANOVA with time as within subject factor and groups as between subject factor showed a significant effect of time F(2,70) =225.572, P < 0.001. Both groups showed significant improvement that sustained during the course of the treatment. There was a significant effect of group F(1,35) =9.080, P = 0.006 and group X time interaction F(2,70) =5.074, P = 0.010. Post hoc analysis revealed at the end of 30 days (P < 0.001) and 60 days (P = 0.03) group K showed significant improvement compared to group D [Table 2b and Figure 3 ].
